- Report
- February 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- February 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- January 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,441GBP
- Report
- April 2025
- 186 Pages
Global
From €3986EUR$4,500USD£3,449GBP
- Report
- August 2025
Global
From €4340EUR$4,900USD£3,755GBP
- Report
- August 2025
- 372 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 374 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 273 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 183 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 474 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 194 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 78 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 194 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Report
- August 2025
- 269 Pages
Global
From €5182EUR$5,850USD£4,483GBP
- Clinical Trials
- July 2025
- 60 Pages
Global
From €1329EUR$1,500USD£1,150GBP
- Drug Pipelines
- July 2025
- 60 Pages
Global
From €1107EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1329EUR$1,500USD£1,150GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1772EUR$2,000USD£1,533GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more